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Abstract
Background: Verbal autopsy (VA) is one method to obtain valid estimates of causes of death in the absence of valid medical
records. We tested the reliability and validity of a VA questionnaire developed for a cohort study in Golestan Province in
northeastern Iran.
Method: A modified version of the WHO adult verbal autopsy was used to assess the cause of death in the first 219 Golestan
Cohort Study (GCS) subjects who died. The GCS cause of death was determined by two internists who independently
reviewed all available medical records. Two other internists (‘‘reviewers’’) independently reviewed only the VA answers and
classified the cause of death into one of nine general categories; they repeated this evaluation one month later. The
reliability of the VA was measured by calculating intra-reviewer and inter-reviewer kappa statistics. The validity of the VA
was measured using the GCS cause of death as the gold standard.
Results: VA showed both good validity (sensitivity, specificity, PPV, and NPV all above 0.81) and reliability (kappa.0.75) in
determining the general cause of death independent of sex and place of residence. The overall multi-rater agreement across
four reviews was 0.84 (95%CI: 0.78–0.89). The results for identifying specific cancer deaths were also promising, especially
for upper GI cancers (kappa = 0.95). The multi-rater agreement in cancer subgroup was 0.93 (95%CI: 0.85–0.99).
Conclusions: VA seems to have good reliability and validity for determining the cause of death in a large-scale adult follow
up study in a predominantly rural area of a middle-income country.
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Introduction
Accurate information on overall and cause-specific mortality is
essential to prioritize the activities of health systems and to
efficiently invest scarce public health and medical care resources
[1,2,3]. The availability of such information is also important for
epidemiologic studies. The standard method to determine the
cause of death is certification by an attending physician, based on
valid medical documents, but this approach may yield unreliable
results in many low- and middle-income countries, especially in
rural and suburban areas. This is mainly due to the lack of
infrastructure and the high cost of collecting the data, which limit
access to information from diagnostic tests and post-mortem
pathology services. Mortality data from these countries are
therefore limited and potentially biased [3,4,5]. One relatively
simple and low-cost alternative for determining a person’s cause of
death which is available in most low-resource countries is the so-
called verbal autopsy (VA) [5,6].
The VA methodology was first developed for investigating
epidemics [7] and was later used for evaluations of outcomes of
specific interventions [8,9] and national mortality surveillance
systems, principally in low-income countries such as India [10].
Several studies have shown that VA gives more valid causes of
death than routine death certificate data in many developing
countries [11,12,13,14,15]. In VA, a trained interviewer ascertains
the symptoms, signs and events during the period leading up to
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death from family members or primary care givers of the deceased
[6,16]. This information is analyzed to derive a probable cause of
death. The most commonly used method for analysis of the
collected information is a ‘‘physician’s review’’, generally per-
formed by more than one physician [6,16]. Other methods, such
as algorithms that can be applied by computer, have been tried but
found to lack validity [17,18,19].
During 2004–2008, the Golestan Cohort Study (GCS) enrolled
more than 50,000 adults in Golestan Province, in northeastern
Iran [20], following a pilot study [21]. Golestan is a low-resource
area of the country, and consequently, reliable clinical data are not
available to determine the causes of death of the residents. Thus
we have applied the VA method as a tool to identify the causes of
death in the GCS. It is estimated that about 60% of the GCS
participants will die at home, and some of them will not have any
medical records accurately documenting their cause of death. VA
represents an appealing approach to determine the cause of death
in this group of subjects. However, it is necessary to validate the
VA questionnaire in this adult population. The majority of VA
validation studies have focused on neonatal and childhood
mortality [12,22,23,24,25,26,27,28,29,30,31,32,33]. Only a few
studies have investigated the validity of VA in adults [12,25,28,32].
Although VA is prone to erroneous estimates of cause-specific
mortality rates due to misclassification [34], several studies have
demonstrated its ability in valid identification of the most common
causes of death in many settings [12,26,27,29,32,35,36]. And even
those who think VA is an imprecise tool for detecting the leading
causes of death suggest that in the absence of other more reliable
methods, VA may be useful as a secondary tool to determine
causes of death in rural areas [6]. Our study is the first attempt to
validate an adult VA questionnaire to be used in a longitudinal
study in a medium income country.
Materials and Methods
The Golestan Cohort Study
The methods of the Golestan Cohort Study (GCS) have been
previously described in detail [20]. In brief, 50,045 adult middle-
aged individuals were enrolled in eastern Golestan Province, Iran
between January 2004 and June 2008. Participants are actively
followed through annual telephone contact to ascertain their vital
and health status. If a participant cannot be reached, family
members, friends, or local health workers are contacted. Moreover,
local health workers in rural areas, called ‘‘Behvarz’’, are contacted
monthly to inquire about any possible outcomes, including death. In
the event of death, the follow-up team performs two main tasks in
parallel. First, a trained general practitioner goes to the homes of the
family members or primary care givers of the deceased and
conducts a VA interview. Second, the team determines which
physicians or hospitals were visited by the decedent and obtains all
medical documents (charts, X-rays, pathology reports, etc) that
could be used to identify the cause of death. These documents may
be available in Golestan or in neighboring provinces.
The GCS follow-up team uses the adult VA questionnaire
originally developed by World Health Organization (WHO) and
the International Network of field sites with continuous Demo-
graphic Evaluation of Populations and Their Health in developing
countries (INDEPTH) [37,38], with some modifications to adapt
to the local situation in Golestan. We tailored the standard VA
questionnaire based on cultural background and education of
study population. We made special attention to the most common
disease and causes of death in the study area. We added some
disease-oriented questions for specific diseases (cardiovascular,
stroke, cancer (esophageal and gastric), diabetes, hypertension,
tuberculosis and asthma) to collect more information by VA. Since
we have already collected the data of life style and personal habits
of the study participants at the enrollment phase of GCS, we
excluded this part of VA questionnaire to save time. Local terms
for some signs/symptoms such as ‘‘dysphagia’’ were applied when
we translated the VA questionnaire to Farsi.
After the VA interview and medical document search are
completed, the results are given to two internists to ascertain the
cause of death. The two internists who review the VA and other
documents are unaware of each other’s diagnosis. When they
disagree on the cause of death, a third senior internist reviews the
VA, the available documents, and also the diagnoses of the first
two internists and makes the final decision. All causes of death are
coded according to the core three digit codes of the International
Classification of Diseases, Tenth Revision (ICD-10) [39]. The
cause of death obtained by this method was considered as the gold
standard for the current validation study. Seventy cases (32%) had
no medical documents, so in these cases the VA-based diagnoses
confirmed by the above method were used as the gold standard.
Validation study
This validation study was conducted on all 219 deaths reported
in GCS participants by the end of January 2005. Copies of all 219
completed VA questionnaires were given to two trained internists,
henceforth referred to as the ‘‘reviewers’’, who were different
individuals from the internists who made the first GCS cause of
death determinations. The reviewers studied the completed VA
questionnaires independently, and made their decisions on the
cause of death based on the VA questionnaire alone, without
having any other medical documents. In order to get an estimate
of within-reviewer reliability of the VA diagnoses, the same two
reviewers were asked to review the VA’s a second time one month
later, without the knowledge that this was a repeat review.
For the purpose of this study the causes of death were
categorized into one of nine major categories. To estimate the
reliability, kappa statistics were calculated for the agreement
between the reviewers’ diagnoses. Both within-reviewer reliability
(comparing the first and second diagnoses of the same reviewer)
and between-reviewer reliability (comparing the diagnoses made
by the two reviewers) were calculated. Multi-rater agreement was
calculated and its confidence interval was calculated using
bootstrap technique. To estimate validity, the VA diagnoses made
Table 1. The distribution of causes of death in all 219
deceased and the subset of 149 deceased with supporting
medical documents.
No. Cause of Death
Complete set
Number (%)
Subset
Number (%)
1 Ischemic Heart Diseases (IHD) 81 (37%) 50 (34%)
2 Cancers 49 (22%) 41 (27%)
3 Cerebrovascular diseases (CVA) 33 (15%) 19 (13%)
4 Transport Accidents 16 (7.4%) 7 (4.7%)
5 Renal diseases 8 (3.8%) 7 (4.7%)
6 Pulmonary diseases 6 (2.8%) 5 (3.3%)
7 Liver diseases 5 (2.4%) 4 (2.6%)
8 Unknown 14 (6.4%) 9 (6.0%)
9 Other 7 (3.2%) 7 (4.7%)
Total 219 (100%) 149 (100%)
doi:10.1371/journal.pone.0011183.t001
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by the two reviewers were compared to the gold standard
diagnoses and the sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and kappa statistics were
calculated for each reviewer-gold standard comparison. As a
sensitivity analysis, the VA validity was once calculated in the
subgroup of 149 cases (68%) who had both VA and medical
documents available for the gold standard cause of death
determinations, and then in all 219 cases.
All study participants had signed written informed consent at
enrollment phase of GCS and ethical approval for the present
study was obtained from the ethics committee of Digestive Disease
Research Center of Tehran University of Medical Sciences.
Results
Of the 219 deceased participants, 133 (60.7%) were male and
86 (39.3%) were female. The mean age (6standard deviation) at
death was 64.4610.7 years. Among the deceased, 91 (41.6%) were
urban and 128 (58.4%) were rural dwellers. In most cases (85%),
the respondent lived with the deceased at the time of death. Of the
219 deaths in the validation study, 70 (32%) had no medical
record other than the completed VA.
Table 1 presents the major causes of deaths according to the
gold standard diagnoses, among the total study population and the
subgroup of 149 subjects (68%) who had both VA and medical
documents available. Ischemic heart disease, cancers, cerebrovas-
cular events, and transportation accidents were the most common
causes of death, respectively, and were responsible for, approxi-
mately 80% of deaths.
Table 2 shows the results of kappa statistics for the within and
between reviewer diagnoses and the comparison of the VA
diagnoses with the gold standard, based on the 149 deaths with
documentation available.
The overall multi-rater agreement across four reviews was 0.84
(95%CI: 0.78–0.89). Most pairwise kappas were higher than 0.80,
indicating good within-reviewer and between-reviewer reliability,
the within-reviewer reliability being somewhat better than
between-reviewer reliability. Agreement between each reviewer
and the gold standard was also good (kappa.0.75).
Sensitivity, specificity, and predictive values for the four most
common causes of death are presented in Table 3. To analyze
sensitivity, these were calculated for the A1 review which had the
lowest agreement with the gold standard and then for the one with
the highest agreement (A2). All estimates were higher than 0.81
Table 2. Kappa (k) statistics for reliability and validity testing of VA interview in 149 documented deaths.
Comparison k statistic in Total k statistic in Males k statistic in Females k statistic in Urban k statistic in Rural
A1 vs A2 0.91 0.87 0.98 0.93 0.89
B1 vs B2 0.89 0.88 0.91 0.92 0.87
A1 vs B1 0.81 0.81 0.81 0.73 0.86
A2 vs B2 0.81 0.79 0.84 0.83 0.79
A1 vs B2 0.80 0.80 0.81 0.79 0.81
A2 vs B1 0.82 0.81 0.83 0.77 0.85
A1 vs GS 0.79 0.77 0.84 0.78 0.86
A2 vs GS 0.86 0.86 0.86 085 0.87
B1 vs GS 0.82 0.83 0.79 0.75 0.87
B2 vs GS 0.82 0.84 0.79 0.79 0.84
A1: reviewer A first diagnosis, A2: reviewer A second diagnosis, B1: reviewer B first diagnosis, B2: reviewer B second diagnosis, GS: gold standard.
doi:10.1371/journal.pone.0011183.t002
Table 3. Validation results for VA reviews in diagnosing cause of death for 4 selected causes in 149 documented deaths.
Cause GS deaths VA deaths Sensitivity (95% CI) PPV (95% CI) Specificity (95% CI) NPV (95%CI)
A1
IHD 50 52 90.0 (81.5–98.5) 86.5 (77.1–96.0) 92.9 (87.8–98.1) 94.8 (90.4–99.3)
Cancer 41 42 97.6 (92.7–100) 95.2 (88.7–100) 98.1 (95.5–100) 99.1 (97.2–100)
Cerebrovascular diseases 19 22 94.7 (84.5–100) 81.8 (65.4–98.3) 96.9 (93.9–99.9) 99.2 (97.6–100)
Transport accidents 7 7 100 100 100 100
A2
IHD 50 57 98.0 (94.0–100) 86.0 (76.8–95.2) 91.9 (86.4–97.4) 98.9 (96.7–100)
Cancer 41 43 100 95.3 (88.9–100) 98.1 (95.5–100) 100
Cerebrovascular diseases 33 32 89.5 (75.4–100) 89.5 (75.4–100) 98.5 (96.3–100) 98.5 (96.3–100)
Transport accidents 7 7 100 100 100 100
A1: review with the lowest kappa according to table 2 (Reviewer A’s first review).
A2: review with the highest kappa according to table 2 (Reviewer A’s second review).
doi:10.1371/journal.pone.0011183.t003
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which indicate good validity. As expected transportation accidents
had the highest validity.
Since the main goal for Golestan Cohort Study is to study the
causes of upper GI cancers in particular and other cancers in
general, we also tested the validity of VA for different types of
cancer. Of 41 cancer deaths (in 149 deaths), 13 were due to
esophageal cancer, the others being due to gastric cancer (n = 5)
liver cancer (4), lymphoma (4), lung cancer (3) leukemia (3), breast
cancer (2) and other cancers (7). In the comparison between A1,
A2, B1 and B2 review results versus GS, the kappas were 0.82,
0.85, 0.78, and 0.85, respectively for all types. The multi-rater
agreement for four reviews was 0.93 (95%CI: 0.85–0.99). In
addition, the validity of VA in detecting upper GI cancers was 0.95
for all reviews.
To check the differences between documented and non-
documented causes of death, we did the same analysis on 219 VA
(Tables 4, 5). The numbers are comparable to those in Table 2, 3.
Discussion
Verbal autopsy seems to be a reliable and valid supplemental
method to assess causes of death in the Golestan Cohort Study
with comparable results in men and women and for patients from
both rural and urban areas. One major reason for the usefulness
of VA in the GCS may be the appropriate modifications
made in the adult questionnaire prepared by WHO and the
INDEPTH [37,38] to adapt it to the local setting. Our results are
consistent with those of most previous studies, showing that the VA
is a reasonably valid tool to ascertain causes of death
[12,26,27,29,32,35,36]. Some other studies are less supportive of
the VA [34], and some even suggest that VA is not a very precise
tool for detecting the leading cause of death among adults [6]. The
reason for inconsistency in results of VA validation studies may be
that VA is a developing method itself [40]. Thus, there are several
variations of VA methodology and questionnaires, and some
studies have not use the ICD coding system for their cause of death
diagnoses. WHO has recently published instructions to improve
the quality and standards for use of this method [41].
We used the VA method in the GCS, which is the first large-
scale prospective population-based cohort study of cancer in the
Middle East, to improve the accuracy of diagnosing the causes of
death of cohort members. The majority of families in the rural
area of Golestan Province prefer their family members to die at
home after a diagnosis of end-stage cancer. About 60% of the
decedents in the current study died at home, and only half of these
had a prior hospital-based diagnosis; for the other half, the VA
Table 4. Kappa statistics for reliability and validity testing of VA interview in 219 deaths.
Comparison k statistic in Total k statistic in Males k statistic in Females k statistic in Urban k statistic in Rural
A1 vs A2 0.89 0.86 0.99 0.90 0.89
B1 vs B2 0.89 0.84 0.91 0.92 0.87
A1 vs B1 0.81 0.78 0.86 0.75 0.86
A2 vs B2 0.84 0.82 0.86 0.85 0.83
A1 vs B2 0.80 0.77 0.83 0.79 0.81
A2 vs B1 0.84 0.83 0.86 0.78 0.88
A1 vs GS 0.80 0.76 0.87 0.80 0.80
A2 vs GS 0.86 0.86 0.86 0.83 0.89
B1 vs GS 0.84 0.83 0.85 0.79 0.88
B2 vs GS 0.84 0.85 0.82 0.79 0.88
A1: reviewer A first diagnosis, A2: reviewer A second diagnosis, B1: reviewer B first diagnosis, B2: reviewer B second diagnosis, GS: gold standard.
doi:10.1371/journal.pone.0011183.t004
Table 5. Validation characteristics of VA interviews in diagnosing cause of death for 4 selected causes in 219 deaths.
Cause GS deaths VA deaths Sensitivity (95% CI) PPV (95% CI) Specificity (95% CI) NPV (95%CI)
A1
IHD 81 88 93.8 (88.5–99.2) 86.4 (79.0–93.7) 91.3 (86.5–96.1) 96.2 (92.8–99.5)
Cancer 49 53 98.0 (93.9–100) 90.6 (82.5–98.6) 97.1 (94.5–99.6) 99.4 (98.2–100)
Cerebrovascular diseases 33 34 90.9 (80.9–100) 88.2 (77.2–99.3) 97.8 (95.7–100) 98.4 (96.5–100)
Transport accidents 16 15 93.7 (93.0–94.5) 100 100 99.5 (98.5–100)
A2
IHD 81 94 98.8 (96.3–100) 85.1 (77.8–92.4) 89.8 (84.7–95.0) 99.2 (97.6–100)
Cancer 49 51 100 96.1 (90.6–100) 98.8 (97.2–100) 100
Cerebrovascular diseases 33 32 90.9 (80.9–100) 93.7 (85.2–100) 98.9 (97.4–100) 98.4 (96.5–100)
Transport accidents 16 16 100 100 100 100
A1: review with the lowest kappa according to table 2 (Reviewer A’s first review).
A2: review with the highest kappa according to table 2 (Reviewer A’s second review).
doi:10.1371/journal.pone.0011183.t005
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seems to be a promising approach to identify at least a general
cause of death.
The kappa statistics obtained in the current study show that VA
generates highly reliable results, at least among the 9 major
categories of causes of death used in our study. Our results showed
both high within–reviewer and between-reviewer reliability. We
also found this method to be valid, with high sensitivity and
specificity when compared to the gold standard diagnoses. Our
results for making the diagnosis of different cancer subtypes also
seem promising. This is especially true for upper gastrointestinal
(UGI) cancers, the main focus of the GCS. Dysphagia, the main
symptom of esophageal cancer, is very characteristic of this
disease, and the availability of at least 10 UGI endoscopy clinics in
the region, three providing free-of-charge endoscopy services to
the GCS subjects, has made it possible to have accurate histologic
diagnoses for almost all UGI cancers.
There are of course several caveats and methodological
considerations related to this method. The gold standard was set
by a combination of diagnoses made by two internists, or a third
internist when the first two internists did not concur. These
physicians used both VA and other clinical documents to
adjudicate the results, but in 32% of the cases both the original
internists and the reviewers in our study had only the VA answers
to review. This lack of additional clinical documents in a third of
the cases might raise concern that our validity estimates were
falsely elevated, but this does not seem to have been the case, since
these estimates were essentially identical in the full group of cases
and in the subgroup which had additional clinical documents. On
the other hand, our results may underestimate the potential
sensitivity and specificity of the VA method because they tested the
diagnosis made by each reviewer separately. In the actual GCS, at
least two internists and perhaps a third one decides on the final
diagnosis, and therefore the results may be more accurate than the
judgment of just one physician.
In conclusion, our results suggest good reliability and good
validity of verbal autopsy in determining the causes of death in a
large-scale adult cohort study in a predominantly rural area in a
developing country. These results add to the current literature on
the use of VA for cohort studies in adult populations.
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